Medpro Safety Products purchases product development rights from Visual Connections

MedPro Safety Products, Inc. (OTCBB: MPSP), a leading developer of transformational technologies that enable safer medication delivery and blood collection systems, has purchased product development rights for a unique, fully passive Insulin Guard self-injector from Visual Connections, owned by Hooman Asbaghi. Mr. Asbaghi is the inventor of MedPro’s fully passive phlebotomy collection devices, which include two versions of a safety blood collection holder, a passive IV catheter, and a safety blood collection set.

“The Insulin Guard meets a significant need in the home healthcare market for a truly passive safety self-injector that can diminish the risk of accidental needle sticks and related transfer of blood borne pathogens”

“The Insulin Guard meets a significant need in the home healthcare market for a truly passive safety self-injector that can diminish the risk of accidental needle sticks and related transfer of blood borne pathogens,” said Walter Weller, MedPro President and COO. “As of 2007, more than 17.9 million Americans had been diagnosed as being diabetic, and an estimated 5.7 million more Americans were undiagnosed , with a direct annual medical cost estimated at $116 billion, according to the National Institute of Health. The NIH also reported that diabetes was the seventh leading cause of death in the United States in 2006.”

Mr. Weller continued, “A substantial portion of the diabetic public, both in the United States and worldwide, administer insulin through routine injections in the home. Sharps that remain exposed after use are responsible for accidental needle sticks in the home each year. Additional needle stick injuries occur during the disposal and transfer of sharps waste from the home environment. The “fully passive” safety system on the Insulin Guard automatically encloses the contaminated end of the needle immediately after use, thus protecting the patient, the patient’s family, and caregivers. Since the contaminated sharp remains completely covered after use, everyone involved in waste disposal is also protected. We are also investigating the possible use of the Insulin Guard in the hospital setting, which would significantly expand the potential market opportunity.”

MedPro’s portfolio of eight sharp systems, which now includes the Insulin Guard, employs the only available “fully passive” safety technology, meaning that the user does not need to consciously deploy the sharp’s safety system. The patient uses the MedPro safety sharp as she or he would any traditional sharp not equipped with a safety mechanism, avoiding any added complications for the patient. Once the MedPro safety mechanism deploys entirely on its own, the used sharp is unable to stick another person.

Visual Connections is transferring this technology to MedPro for a five percent royalty on adjusted net sales after commercialization. MedPro intends to market the Insulin Guard to both current and potential global medical device partners who would in turn brand and sell the Insulin Guard to their worldwide customer base.